Evidence map›Paper›PMID 28613102›Full record

ArticlemAbs

A high-throughput platform for population reformatting and mammalian expression of phage display libraries to enable functional screening as full-length IgG.

Xiaodong Xiao, Julie A Douthwaite, Yan Chen, Ben Kemp, Sara Kidd, Jennifer Percival-Alwyn, Alison Smith, Kate Goode, Bonnie Swerdlow, David Lowe and 3 more

Abstract read
In one paragraph

Article in mAbs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2017
    Review
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xiaodong Xiaoa Department of Antibody Discovery and Protein Engineering , Gaithersburg , MD , USA.
Julie A Douthwaiteb Department of Antibody Discovery and Protein Engineering , Cambridge , UK.
Yan Chena Department of Antibody Discovery and Protein Engineering , Gaithersburg , MD , USA.ORCID http://orcid.org/0000-0002-2571-913X
Ben Kempb Department of Antibody Discovery and Protein Engineering , Cambridge , UK.
Sara Kiddb Department of Antibody Discovery and Protein Engineering , Cambridge , UK.
Jennifer Percival-Alwynb Department of Antibody Discovery and Protein Engineering , Cambridge , UK.
Alison Smithb Department of Antibody Discovery and Protein Engineering , Cambridge , UK.
Kate Goodeb Department of Antibody Discovery and Protein Engineering , Cambridge , UK.
Bonnie Swerdlowc Department of Respiratory, Inflammation and Autoimmune Diseases , Gaithersburg , MD , USA.
David Loweb Department of Antibody Discovery and Protein Engineering , Cambridge , UK.
Herren Wua Department of Antibody Discovery and Protein Engineering , Gaithersburg , MD , USA.
William F Dall'Acquaa Department of Antibody Discovery and Protein Engineering , Gaithersburg , MD , USA.
Partha S Chowdhurya Department of Antibody Discovery and Protein Engineering , Gaithersburg , MD , USA.ORCID http://orcid.org/0000-0003-0990-4658

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phage display antibody libraries are a rich resource for discovery of potential therapeutic antibodies. Single-chain variable fragment (scFv) libraries are the most common format due to the efficient display of scFv by phage particles and the ease by which soluble scFv antibodies can be expressed for high-throughput screening. Typically, a cascade of screening and triaging activities are performed, beginning with the assessment of large numbers of E. coli-expressed scFv, and progressing through additional assays with individual reformatting of the most promising scFv to full-length IgG. However, use of high-throughput screening of scFv for the discovery of full-length IgG is not ideal because of the differences between these molecules. Furthermore, the reformatting step represents a bottle neck in the process because each antibody has to be handled individually to preserve the unique VH and VL pairing. These problems could be resolved if populations of scFv could be reformatted to full-length IgG before screening without disrupting the variable region pairing. Here, we describe a novel strategy that allows the reformatting of diverse populations of scFv from phage selections to full-length IgG in a batch format. The reformatting process maintains the diversity and variable region pairing with high fidelity, and the resulted IgG pool enables high-throughput expression of IgG in mammalian cells and cell-based functional screening. The improved process led to the discovery of potent candidates that are comparable or better than those obtained by traditional methods. This strategy should also be readily applicable to Fab-based phage libraries. Our approach, Screening in Product Format (SiPF), represents a substantial improvement in the field of antibody discovery using phage display.

Indexed as

AntibodyIgGphage displayscFvScreen in Product Format (SiPF)

Identifiers

PMID28613102
PMCPMC5540111

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.